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Abstract
Background: Outbreaks of emerging infectious diseases, especially those of a global nature, require rapid epidemiological
analysis and information dissemination. The final products of those activities usually comprise internal memoranda and
briefs within public health authorities and original research published in peer-reviewed journals. Using the 2003 severe
acute respiratory syndrome (SARS) epidemic as an example, we conducted a comprehensive time-stratified review of the
published literature to describe the different types of epidemiological outputs.
Methods and Findings: We identified and analyzed all published articles on the epidemiology of the SARS outbreak in
Hong Kong or Toronto. The analysis was stratified by study design, research domain, data collection, and analytical
technique. We compared the SARS-case and matched-control non-SARS articles published according to the timeline of
submission, acceptance, and publication. The impact factors of the publishing journals were examined according to the
time of publication of SARS articles, and the numbers of citations received by SARS-case and matched-control articles
submitted during and after the epidemic were compared. Descriptive, analytical, theoretical, and experimental
epidemiology concerned, respectively, 54%, 30%, 11%, and 6% of the studies. Only 22% of the studies were submitted,
8% accepted, and 7% published during the epidemic. The submission-to-acceptance and acceptance-to-publication
intervals of the SARS articles submitted during the epidemic period were significantly shorter than the corresponding
intervals of matched-control non-SARS articles published in the same journal issues (p,0.001 and p,0.01, respectively). The
differences of median submission-to-acceptance intervals and median acceptance-to-publication intervals between SARS
articles and their corresponding control articles were 106.5 d (95% confidence interval [CI] 55.0–140.1) and 63.5 d (95% CI
18.0–94.1), respectively. The median numbers of citations of the SARS articles submitted during the epidemic and over the
2 y thereafter were 17 (interquartile range [IQR] 8.0–52.0) and 8 (IQR 3.2–21.8), respectively, significantly higher than the
median numbers of control article citations (15, IQR 8.5–16.5, p,0.05, and 7, IQR 3.0–12.0, p,0.01, respectively).
Conclusions: A majority of the epidemiological articles on SARS were submitted after the epidemic had ended, although
the corresponding studies had relevance to public health authorities during the epidemic. To minimize the lag between
research and the exigency of public health practice in the future, researchers should consider adopting common,
predefined protocols and ready-to-use instruments to improve timeliness, and thus, relevance, in addition to standardizing
comparability across studies. To facilitate information dissemination, journal managers should reengineer their fast-track
channels, which should be adapted to the purpose of an emerging outbreak, taking into account the requirement of high
standards of quality for scientific journals and competition with other online resources.
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Emerging infectious diseases have become a major public health
concern over the last two to three decades [1,2]. When such an
outbreak occurs, real-time collection, analysis, and dissemination
of epidemiological information are key factors contributing to the
effective and rapid control of the epidemic [3]. The first challenge
for epidemiologists is to develop new surveillance and alert tools to
detect in real time the events emerging anywhere in the world, and
not just in highly developed countries [4,5]. Upon detection of the
outbreak, appropriate epidemiological studies should be launched
immediately to help identify the causative agent, investigate the
possible routes and modes of its transmission, define and validate
diagnostic criteria, evaluate candidate treatments, forecast the
spread of the epidemic, devise and evaluate evidence-based
prevention, and monitor policies and strategies [6–8]. Hence,
the outbreak of an emerging infectious disease causes a heavy
epidemiological workload shared by public health specialists from
national and international agencies, and academic epidemiologists.
The importance of the rapid diffusion of public health information
has long been recognized, and specialized international and
national papers or Web bulletins are now made available during
the course of outbreaks. However, journals remain the primary
channel for communication of research. In this study, we analyzed
the process according to which the results of academic
epidemiological research are submitted and then formally
published, during and after the outbreak of an emerging infectious
disease. The proposed analysis concerns both the epidemiologists
who submit their research to journals, and the journal editors who
make decisions about the publication of the submitted research.
The 2003 severe acute respiratory syndrome (SARS) epidemic
[9,10] provided a model of an emerging infectious disease
outbreak that occurred in the information-and-computerization
age, which already has available real-time information systems,
large databases, sophisticated statistical and mathematical analy-
ses, and models. We studied the academic response to the SARS
epidemic, and the resulting analysis may be viewed as a dissection
of the scientific production on an epidemic—including the
dynamics of this production in the course of the outbreak. Our
analysis focused on four aspects: (1) distribution of the epidemi-
ologists’ workload among the different subspecialties and meth-
odologies; (2) the characteristics of the epidemiological studies
published in terms of design, data collection, statistical analysis,
quality assurance, and quality control procedures used; (3) the
timeline for the publication of the scientific results; and (4) the
scientific impact of those publications as compared to control
publications issued simultaneously.
Materials and Methods
Literature Search
We searched bibliographic databases for all published articles
on epidemiology—defined as the study of the distribution and
determinants of health-related states or events in specified
populations, and the application of this study to control of health
problems [11]—of the SARS epidemic in Hong Kong [12] and
Toronto [13]. Hong Kong and Toronto were chosen because both
cities, one in Asia and the other in North America, were strongly
affected by the epidemic and have highly developed academic and
public health infrastructures [14], and the results of the
Table 1. Breakdown of the 11 major epidemiological research domains according to categories 1–4.
Category Research Domain Detailed Research Objectives
1. Investigation and surveillance Description of the outbreak Time, place, and persons
Search for causative agent Identification
Characteristics
Transmission Determine the modes and routes of transmission
Estimate the transmission probability and variability
Predict future trends of the present outbreak
Risk factors Determine the risk factors and disease determinants
2. Case management Clinical presentations Describe the clinical features, pathophysiological evolution,
immune response, and associated clinical complications
Diagnostic assays Development and evaluation of their sensitivity and specificity
Treatments and medical interventions Assess efficacy and adverse events of treatment and medical
interventions
Prognosis Describe patient outcomes
Identify prognostic factors
Medical decision making Promote planning and policy-making by health services
3. Prevention and control Prevention and control measures Describe the use of specific control measures in the population
Estimate and evaluate effectiveness of the control measures
Develop methods and/or tools for real-time monitoring during the
outbreak
4. Psychobehavior Psychobehavioral investigations Assess the level of personal knowledge and perception of risk
Assess the personal attitudes and preventive measures taken
regarding the outbreak threat
Evaluate SARS-related individual psychological and social impacts
doi:10.1371/journal.pmed.1000272.t001
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almost exclusively published in English-language journals.
The entire literature identification–selection process is presented in
Figure S1. Two literature searches were conducted: first, the
MEDLINE database via PubMed and, second, the Science Citation
Index Expanded and the Social Sciences Citation Index databases
that we accessed via the Web of Science (Thomson Reuters). We
searched for alljournal articles written inEnglish whose main studied
subject was the 2003 SARS epidemic in Hong Kong and Toronto.
Our study focused on articles published during the SARS epidemic
and the 4 y thereafter (e.g.,published between 1 January 2003 and 31
July 2007, assuming that most pertinent literature on an epidemic is
produced within this period of time). We defined 5 July 2003, when
the World Health Organization (WHO) reported that the last human
chain of SARS transmission had been broken [15], as the end of the
SARS epidemic.
The literature search was done in 2007, and updated on 11
February 2009. First, we used broad search equations to maximize
retrieval sensitivity. Then, we finalized the search by removing all
articles with at least one of the following seven exclusion criteria:
(1) main study objective was not the study of SARS; (2) data
analyzed in the study were not collected in Hong Kong or
Toronto; (3) not a study on epidemiology (e.g., animal ecology); (4)
not an original study (e.g., commentary, summary, review); (5)
studies using only qualitative methodology, as defined by Critical
Appraisal Skills Programme guidelines for qualitative research
[16]; (6) study sample size #5; (7) full text of the article was
unavailable: a request for a reprint of the article that we sent by e-
mail to all corresponding authors of the articles for which we could
not retrieve the full text through the Internet (either in open-access
journals or in journals for which our institutions or the Inter-
University Library of Medicine had a subscription) resulted in an
absence of response. Two of the authors (WX and A-JV)
independently applied the exclusion criteria to the same random
sample of 100 articles. Good agreement was found between the
two authors’ selections (k statistic: 0.86) [17]. Subsequently, review
of the whole initial set of articles by the first author (WX) resulted
in the final bibliographic database that was built with EndNoteX1
software (Thomson Reuters).
To compare the publication timelines of academic research articles
with that of public health information, we also searched MEDLINE
for public health reports mentioning the 2003 Hong Kong and/or
Toronto SARS epidemic published in four public health bulletins
during the SARS epidemic and the 4 y thereafter: Morbidity and
Mortality Weekly Report for the Centers for Disease Control and
Prevention (CDC), The Weekly Epidemiological Record and Bulletin of the
World Health Organization for the WHO, and Canada Communicable
Disease Report for the Public Health Agency of Canada. At the time of
the SARS epidemic, Communicable Diseases Watch, a bulletin of the
Centre for Health Protection, Department of Health of Hong Kong
was not yet available (its first issue appeared on 13 June 2004). The
literature search was done on 15 May 2009.
Data Analyzed
Articles were classified into four large categories (investigation
and surveillance, case management, prevention and control,
psychobehavior) and in 11 research domains (Table 1) on the
basis of the main objective of the study, as stated by the authors.
We conducted a detailed analysis of the study designs, and the
information given by the authors on the statistical, informatics,
and quality-control methods. A data-collection grid was devised
(Table S1). For each retained article, we recorded the study type
and design, the type and size of the sample population, the
software used for data management and statistical analyses, and
the quality assurance and quality-control processes described in
their Materials and Methods. The collected data were coded in a
relational database (Access, Microsoft Office 2003).
Publication Timeline and Citations of SARS Studies
The timeline of publication process of the articles and their
citations were determined for articles whose submission, accep-
tance, and publication dates were known. Submission and
acceptance dates were obtained from the information provided
by the journal. The publication date was defined as the date of the
article’s full text availability: when the date of print publication
and the date of online publication were both available, the
publication date was defined as the earliest of these. When only the
month of publication was available, the publication date was set at
the 15th of that month. The numbers of citations of articles were
those provided by the Web of Science (Thomson Reuters) on 12–
13 January 2009.
In order to find a potential particular pattern of the SARS studies
in terms of publication timeline and citations, as compared to
comparable studies in other fields, two case-control studies were
performed. The first compared the submission-to-acceptance-to-
publication sequence for SARS-case versus control articles. The
control articles were defined as the two research articles following the
SARS-case article published in the same volume and issue of the
journal that did not concern SARS. The second case-control study
compared the numbers of SARS-case and control article citations. In
this analysis, the control articles of a case article were all other
research articles published in the same issue and volume of the
journal. The two case-control studies were based on the SARS
articles submitted within 2 y after the epidemic, and analyses were
done separately for articles submitted during and after the epidemic.
In addition, we studied the timeline trend of impact factors of
the journals in which the SARS articles had been published. Those
impact factors were obtained in the Journal Citation Reports
database (Thomson Reuters).
Figure 1. Distribution of the 311 SARS epidemiology papers in
the 11 research domains (see Table 1). The studies corresponding
to the ‘‘Case management’’ and ‘‘Investigation and surveillance’’
categories represented 52% and 23% of the 311 studies, respectively.
doi:10.1371/journal.pmed.1000272.g001
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The R statistical freeware (R version 2.6.1, The R Foundation
for Statistical Computing) [18] software was used for obtaining all
random samples and for all statistical analyses. The Kruskal-Wallis
test was used to compare the medians of SARS articles’
publication dates for the 11 research domains, and the
submission-to-acceptance intervals, the acceptance-to-publication
intervals, and the numbers of citations of SARS articles submitted
during the epidemic and over the 2 y thereafter. The Kaplan-
Meier method was used to represent the time-to-acceptance and
the time-to-publication distributions, and then compared by the
log-rank test. Cox models with a robust variance estimation that
accounts for matching, were fitted to provide hazard ratio (HR) as
a measure of the effect size, with 95% confidence interval (CI).
The Wilcoxon signed-rank test was used to compare the
distributions of the numbers of SARS article citations and of the
citations of their corresponding control articles. Dispersions in
individual values were expressed with interquartile range (IQR).
The Jonckheere test [19] was used to assess the existence of a time
trend for the median impact factor of journals in which SARS
articles were published. In all tests, the statistical significance was
defined as p#0.05.
Table 2. Methodological characteristics of the published epidemiological studies on SARS.
Characteristic (n Articles) Category Subcategory n (%
a) Studies
Type of study (152) Descriptive epidemiology 82 (54)
Analytical epidemiology 45 (30)
Theoretical epidemiology 16 (11)
Experimental epidemiology 9 (6)
Study design (152) Cross-sectional studies 30 (20)
Cohort studies Descriptive (longitudinal) cohort 32 (21)
Prospective cohort 12 (8)
Historical cohort 20 (13)
Case-control studies 8 (5)
Experimental studies Intervention trials 2 (1)
Clinical trials 7 (5)
Mathematical modeling 16 (11)
Molecular studies 11 (7)
Diagnostic studies 14 (9)
Case-definition (118) WHO and/or CDC case definition 80 (68)
Local health authority’s or authors’ case definition 19 (16)
Not specified 19 (16)
Study setting (152) Hospital 106 (70)
Community 33 (22)
Hospital and community 13 (9)
Data-collection instrument
b (152) Questionnaire 50 (33)
Biological specimen collection 60 (39)
Physical examinations 33 (22)
Environmental sample 2 (1)
Hospital, medical, or exposure records 20 (13)
Secondary data
c 49 (32)
Not specified 2 (1)
Quality-assurance processes
for data collection (152)
Indicated in the article 53 (35)
Not specified 99 (65)
Quality-control activities for
data collection (152)
Indicated in the article 19 (13)
Not specified 133 (88)
Software for database management (152) Indicated in the article 8 (5)
Not specified 144 (95)
Software for data analysis (114) Indicated in the article 66 (58)
Not specified 48 (42)
aPercentages do not add up to 100 because of rounding figures.
bPercentages in this section do not add up to 100% because multiple answers were possible.
cReanalysis of previously used data.
doi:10.1371/journal.pmed.1000272.t002
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Literature Search
The initial literature search provided 932 and 298 articles
concerning the epidemic in Hong Kong and Toronto, respectively
(see in Figure S1 the flowchart detailing the selection process of
SARS articles). Applying the exclusion criteria resulted in the final
selection of 263 and 58 articles for Hong Kong and Toronto,
respectively. Because ten of the selected articles concerned the
epidemic in both Hong Kong and Toronto, the final bibliographic
database contained 311 different articles. Dates of online
publication were obtained for 164 of the 311 SARS articles.
Because ten articles had their online version posted after their
print version, analyses involving publication dates were based on
154 online and 157 print publication dates. In addition, we
selected a random sample of 100 out of the 263 articles dealing
with the Hong Kong epidemic, and retained all articles dealing
with the Toronto epidemic (n=58) for further detailed analyses.
These time-consuming analyses were performed on this subsample
set of articles in order to facilitate feasibility. Because six studies
concerned the epidemic in both cities, this final subset consisted of
152 articles. The detailed list of the whole set and subset articles
(n=311 and n=152, respectively) is given in the Text S1.
The search of public health bulletins identified 29 SARS reports
published on the Hong Kong and/or Toronto epidemic, among
which 20 (69%) were published during the epidemic (see Figure
S2): 12 in The Weekly Epidemiological Record, zero in Bulletin of the
World Health Organization, two in Morbidity and Mortality Weekly
Report, three in Canada Communicable Disease Report, and three others
published first in Morbidity and Mortality Weekly Report and then in
Canada Communicable Disease Report. These reports focused on the
description of the outbreak situation (13/20), an update on the
number of SARS cases (ten out of 20), prevention and control
policies (ten out of 20), and descriptions of the clinical features or
the case definition (seven out of 20). Such reports cannot obviously
be considered as original peer-reviewed research articles and were
not included in the studies related to the research domains or to
citation impact.
Typology of Studies
The distributions of the 11 research domains addressed by the
311 articles are shown in Figure 1. The majority (52%) of the
published studies were in the ‘‘case-management’’ category, with
16% concerning the assessment of diagnostic tests or criteria.
‘‘Investigation and surveillance’’ represented 23% of the studies;
19% were ‘‘psychobehavioral studies’’; and 6% concerned
‘‘prevention and control.’’
The detailed analysis (Table 2) performed on the subset of 152
articles showed that the majority of the studies were descriptive
epidemiology (54%), 42% were cohort studies, and 20% were
cross-sectional studies. Case-control design and experimental
studies were rare (5% and 6%, respectively). The majority of
studies (70%) were conducted in hospitals. One-third of the studies
used a questionnaire to collect data. Post mortem findings were
reported in four articles. The use of data initially collected for
another reason (hospital records, 13%) or secondary data analysis
(i.e., the use of data already analyzed in previous studies, 32%) was
frequent.
Study Population
The study population was composed of SARS patients in 118
(78%) studies, individuals from the general population in 20
(13%), non-SARS health care workers in 27 (18%), and other
types (e.g., patients without SARS, households of SARS patients,
and quarantined individuals) in 19 (12%) (Figure 2). The largest
SARS-patient sample in a single study was 4,536 [20], obtained
by pooling Hong Kong and Toronto patients with patients from
other affected zones (e.g., Beijing, Singapore) to simulate
strategies for controlling SARS outbreaks. The largest sample
sizes for the other study population groups were: 12,000 for the
general population [21] in a study estimating the seropositivity
rate of the SARS coronavirus in the Hong Kong region; 37,174
for health care workers [22] in a study assessing the effectiveness
of an herbal formula; and 8,044 for other populations [23] in a
study estimating the ability of laboratory tests to discriminate
SARS patients and patients with other causes of community-
acquired pneumonia.
Quality Assurance and Quality Control
Among the 118 studies including SARS patients, 16% did not
specify the SARS case-definition criteria applied, 68% used the
WHO and/or CDC criteria, and 16% used the criteria established
by authors or local health authorities. Among the 120 (79%)
studies that collected original data, only two specified double-data
entries and ten stated that they checked the data for errors through
manual or systematic inspection. For 70% of the 30 studies with
data on chest radiographs, the radiologists’ evaluations had been
double-blinded. Researchers reported using statistical or mathe-
matical techniques to analyze the data in 114/152 (75%) studies.
Among them, statistical methods were not described in seven (6%)
articles, and the software used to analyze the data was not
indicated in 48 (42%). The database-management software was
given in only 5% of the 152 studies.
Figure 2. Sample sizes used in the epidemiological studies on
SARS (152 articles). ‘‘Other’’ indicates studies in which patients
without SARS, households of SARS patients, and quarantined individ-
uals were studied. The sum of n is greater than 152 because several
studies analyzed more than one population. Box-plot representation:
The horizontal line inside the box represents the median; the lower and
upper borders of the box represent the 25th and 75th percentiles,
respectively; the whiskers correspond to extending to 1.5 times the box
width (i.e., the IQR) from both ends of the box, and the circles represent
values outside that interval. Whenever the minimum or maximum
observed value is within the whisker interval, the alternative limit of the
corresponding whisker becomes the corresponding minimum or
maximum observed value.
doi:10.1371/journal.pmed.1000272.g002
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The 311 SARS articles comprising our entire database were
published in 137 different journals. Among them, 50 (37%)
journals published more than one SARS article. Three journals
published more than ten articles: 32 (10%) publications appeared
in Emerging Infectious Diseases, 11 (4%) in The Lancet, and 11 (4%) in
Radiology. Seventeen studies were published during the epidemic.
The first ten published studies appeared in The Lancet (7/10) and
The New England Journal of Medicine (3/10). The next seven were
published in The Journal of the American Medical Association (2/7),
Clinical Chemistry (1/7), Science (1/7), British Medical Journal (2/7),
and Canadian Medical Association Journal (1/7).
Publication Timeline
We derived the publication timeline for each of the research
domains. Small percentages of articles were submitted or
published for each research domain during the epidemic period.
The maximum was 38% (21/55) of the articles in the category
clinical presentations; the minimum was 3% (2/59) in the category
psychobehavioral investigations. Only 10% (5/50), 17% (4/23),
and 21% (4/19) of the articles dealing with diagnostic assays,
treatments, and prevention and control, respectively, were
submitted or published during the epidemic. The median
publication dates for the different research domains (see Figure 3)
differed significantly (p,0.001).
The date-of-submission distribution indicates that the academic
response to the epidemic was rapid (Figure 4). In Hong Kong and
Toronto, respectively, the 2003 SARS epidemic started on 7 and
15 March, and lasted until 23 June and 2 July [15]. On 31 March,
a few weeks after the onset of the epidemic, the first articles
reporting on the Hong Kong [24] and Toronto [13] outbreaks
were both published online in the same journal. However, only a
minority of the total number of SARS articles submitted (34/157,
22%), accepted (14/185, 8%), or published (21/311, 7%, with
four, one, and 16 articles published only in an online version, only
in a print version, and in both versions, respectively) were available
to the scientific community up to and including 5 July, the end of
the epidemic. The median date of article submission was 27
February 2004 (IQR: 30 July 2003–15 January 2005); their
median acceptance and publication dates were 30 June (IQR: 02
December 2003–02 June 2005) and 16 September 2004 (IQR: 15
February 2004–15 July 2005), respectively, 124 and 202 d later.
The median date of article print publication was 31 October 2004
(IQR: 15 February 2004–15 August 2005), 48 d after the median
date of the earliest publication.
Figure 5 shows the Kaplan-Meier curves representing the
distributions of the submission-to-acceptance and acceptance-to-
publication intervals for the SARS articles submitted during (left,
Figure 5A and 5C, respectively) and after the epidemic (right,
Figure 5B and 5D, respectively). The SARS articles submitted
during the epidemic were accepted and published more rapidly
than the non-SARS control articles (HR=2.7, 95% CI 1.5–4.6,
p,0.001 and HR=1.7, 95% CI 1.1–2.5, p,0.01, respectively).
The difference of median submission-to-acceptance intervals
between SARS articles and their corresponding control articles
was 106.5 d (95% CI 55.0–140.1) (Figure 5A); and the difference
of median acceptance-to-publication intervals between SARS
articles and their corresponding control articles was 63.5 d (95%
CI 18.0–94.1) (Figure 5C). In contrast, the submission-to-
acceptance and acceptance-to-publication intervals of the SARS
Figure 3. Publication dates of SARS papers in the 11 research domains (311 articles). The gray graph on the left shows the timing of the
Hong Kong and Canadian epidemics (sum of both daily numbers of SARS cases), with a peak corresponding to 117 and 114 SARS cases on 24 and 25
March 2003. Hong Kong SARS data were from the SARSID database [33]; Canadian data were from the Public Health Agency of Canada [34]. The
vertical line points to 5 July 2003, the date WHO declared that the last human chain of transmission had been broken. Box-plot representation: as in
Figure 2 except box representation is horizontal; the colors indicate the study categories (see insert in Figure 1; green, case management; blue,
investigation and surveillance; red, psychobehavior; yellow, prevention and control).
doi:10.1371/journal.pmed.1000272.g003
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from those of the control articles (p=0.08 and p=0.34,
respectively). In addition, the submission-to-acceptance and
acceptance-to-publication intervals for SARS articles submitted
during the epidemic differed significantly from the corresponding
intervals of SARS articles submitted over the 2 y thereafter
(p,0.001 and p,0.01, respectively).
Journal Impact Factors and Article Citations
The impact factors were available for 130 journals in which 299
SARS articles were published; the remaining 12 articles were
published in seven journals that were not indexed in the Journal
Citation Report database. The impact factors of these 130 journals
ranged between 0.437 and 50.017 (median of 4.131 [IQR: 2.51–
6.50]). The impact factors of the journals in which the articles on
SARS were published decreased significantly (p,0.0001) with
publication dates (Figure 6). The case-control study on the
citations received by the articles included 123 of the 129 case
articles submitted within 2 y after the epidemic (33 during the
epidemic, 90 after the epidemic) and 3,659 control articles, as the
number of citations was not available for six of the 129 case articles
submitted. The median numbers of citations of the SARS articles
submitted during the epidemic and over the 2 y thereafter were 17
(IQR: 8.0–52.0) and eight (IQR: 3.2–21.8), respectively; this
difference was significant (p,0.01). Considering these two periods,
the number of SARS-article citations was significantly higher than
the median number of citations of their control articles (15, IQR
8.5–16.5, p,0.05, and 7, IQR 3.0–12.0, p,0.01, respectively).
Discussion
Herein we reported our analysis of the scientific literature on the
epidemiology of the SARS epidemic in Hong Kong and Toronto
taken as a model of an emerging infectious disease epidemic. We
outlined the distribution of the workload among the traditional
categories of epidemiological studies and methodologies. We
showed that the time to disseminate study results could be quite
long, in contrast to what would have been expected during a
period of high public health alertness. The length of time to
publish study results is dependent on several factors, which may
Figure 4. Timeline of SARS epidemiology publications on the Hong Kong and Toronto epidemic. The curves (red, green, and both blue
lines) show the cumulative distributions of the 311 articles published by 15 September 2007, according to the publication and acceptance or
submission dates for the 185 and 157 articles, respectively, for which the information was available. The solid blue line shows the cumulative
distribution of the publication dates, defined as the earliest date of publication, print or online. The dotted blue line shows the cumulative
distribution of the print publication dates. The dashed yellow line shows the cumulative distributions of the 29 public health bulletins published by
15 September 2005 according to their publication dates. For comparison, the timing of the Hong Kong and Canadian epidemic is shown in gray on
the left, as described in the legend to Figure 3. The vertical line points to 5 July 2003, the date WHO declared that the last human chain of
transmission had been broken. The insert is a superposition of the publication timeline and course of the epidemic.
doi:10.1371/journal.pmed.1000272.g004
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questionnaires, to write the paper, and to choose the journal to
submit to, and if rejected by this journal, to choose the next
journals to submit to) or journal-related (time to find reviewers, to
get reviews, to make a decision for publication, to publish). Our
results indicate that the SARS articles submitted during the
epidemic that were eventually published were more rapidly
processed than control articles.
We chose to analyse a subset of the studies made on SARS, and to
restrict our analysis to data that might be accurately quantified; in
particular we only analyzed published papers. Hong Kong and
Toronto accounted for only 2,005 (24%) of SARS cases out of a total
of 8,422 cases worldwide. Nevertheless, Hong Kong and Toronto are
indeed the cities with the highest number of cases in their respective
continents, Asia and America. We also refrained from attempting to
obtain qualitative data on each paper, as it could only have been done
through surveying authors, editors, and journal managers to learn the
numbers of previous submission of their papers (if any) by the authors,
the nature of the decision process by editorial boards, etc. This
information might be of great interest, but would result in low quality
data, exhaustivity, and bias being highly dependent on the qualitative
data on the papers. Therefore, we chose to analyse limited
information, available in public databases, and set up a design
allowing an unbiased comparison of SARS and control articles, and
replication of the results.
Our detailed results showed that, during the outbreak of an
emerging infectious disease, descriptive epidemiology predominat-
ed in the published literature (Table 2). Nearly four-fifths (78%,
see Results, ‘‘Population Study’’) of the published articles
concerned studies on SARS patients conducted in a clinical
setting. A large number of these investigations were devoted to
assessing real-time diagnostic tools. At the same time, 22% of the
retrieved articles did not concern SARS patients per se, reflecting
the broader need of investigation in the community at-large when
mitigation strategies are addressed. In particular, the results of our
analysis highlighted the high proportion of published articles on
psychobehavioral investigations (Figure 1): during such an
outbreak, these investigations are indeed key elements for the
implementation of control policies in the hospital and in the
general population.
In large measure, the identified articles had relevance for public
health authorities during the epidemic. However, only very few of
Figure 5. Comparison of publication intervals for case and control articles during and after the SARS epidemic. Submission,
acceptance, and publication dates were available for 129 SARS articles submitted within 2 y (including 33 submitted during the epidemic), but were
unavailable for three out of 129 couples of control. The Kaplan-Meier curves show the proportions of submitted manuscripts (ordinate) that took
more than x d (abscissa) to be published. The comparisons of the submission-to-acceptance intervals between SARS articles and their control articles
are shown for the SARS articles submitted (A) during the epidemic and (B) within 2 y after the end of the SARS epidemic. The comparisons of the
acceptance-to-publication intervals between SARS articles and their control articles are shown for the SARS articles submitted (C) during the epidemic
and (D) within 2 y after the end of the SARS epidemic.
doi:10.1371/journal.pmed.1000272.g005
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epidemic (see Figure 4 and Results, ‘‘Publication Timeline’’).
Some public health information of immediate interest to the
general public and health authorities and personnel were provided
in a timely manner through specialized international or national
public health bulletins: the first report published on the SARS
epidemic mentioning Hong Kong and Vietnam was published on
14 March 2003 [25], 2 d after the first WHO alert concerning the
SARS threat, and 69% of the public health information was
published before the end of the SARS epidemic (Figure 4).
However, our analysis of peer-reviewed journal articles (the main
target of our study) quantified a worrying fact. Although academic
articles providing data on this emerging disease received good
impact scores in terms of the numbers of citations, they took a long
time to be accepted and published (Figure 5), even though our
findings demonstrated that journal managers had already
accelerated the publication process during the epidemic
(Figure 5A and 5C). The interval between submission and
publication, and especially the acceptance-to-publication interval,
is an important issue since many academic articles were aimed at
solving practical clinical and epidemiological problems. The task
of journal managers is difficult because speed to publication,
although necessary, should not compromise review or the standard
of quality of accepted articles. Our findings might encourage even
more scientific journal managers to widely open online sections
that could be activated upon detection of an emerging infectious
disease outbreak, and possibly use a different review-publication
system, so as to enhance the speed of publication. For example,
several journals propose a specific section of manuscript
submission involving dedicated fast management of those
manuscripts that deserve rapid evaluation (e.g., ‘‘fast-track
publication’’ in The Lancet, ‘‘rapid review’’ in The New England
Journal of Medicine).
Visible changes in the dissemination of scientific information do
not only concern speed of publication, they also acknowledge the
technological and societal changes in the use of modern
communication tools (Web 2.0). In 2007, the Nature Publishing
Group launched Nature Precedings, which aims to rapidly disseminate,
share, and discuss prepublication data [26]. More recently, the
BMJ group launched a Web site on the 2009 H1N1/A pandemic
flu [27] where articles, podcasts, learning modules, and other
resources are available on a range of issues. PLoS Currents: Influenza
is another such recent initiative [28] for rapid and open sharing of
new scientific data, analyses, and ideas, the submissions being
rapidly screened by a group of moderators who are leading
researchers in the field. The rapid progress of information systems
is likely to facilitate further similar initiatives. The methodology
and the results of our study may be used in the future as a basis for
estimating the impact of such changes in the publishing landscape
in terms of speed of dissemination and quality.
Our results indicate that the publication delay is also heavily
dependent on the researchers themselves: 78% of the articles
analyzed in this study (i.e., only those eventually published) were
submitted after the epidemic. In some instances, this delay could
be explained by a previous unsuccessful submission to a high
impact journal during the epidemic before the final submission,
which is the only one that could be analyzed herein. However, the
primary cause of the delay is undoubtedly the time necessary for
the authors to design the study, acquire the data, and finalize the
paper. This bottleneck could be reduced by developing a series of
ready-to-use information technologies, to improve timeliness and,
thus relevance, and further, to improve standardization, and thus
comparability across studies in the event of an outbreak. Just as
theoretical modelers have shifted to real-time approaches, for
example, to estimate the basic/effective reproduction number of
an epidemic [29], ‘‘field epidemiologists’’ should benefit from real-
time tools for protocol writing and questionnaire design, and have
them readily available on the Web so as to be prepared for the
next emerging disease outbreak. Others, too, have advocated the
need to prepare ready-to-use forms for clinical research on the
2009 H1N1/A pandemic [30]. Specific information systems
dedicated to real-time research on the epidemic would provide
valuable assistance for designers of future studies. Inspired by the
guidelines recommended by STROBE [31] for observational
studies, and CONSORT [32] for randomized controlled trials,
such systems would offer standardized tools and protocols to assure
adherence to good epidemiological practices. Our observations
strongly suggest the need for coordinated international action
dedicated to the development of such systems that, surprisingly,
are not yet available in our information age.
The SARS outbreaks in Hong Kong and Toronto occurred
nearly 7 y ago; and this amount of time was required to study the
timeline of publications on these outbreaks, especially for
analyzing citations of the SARS papers with an appropriate
perspective. The approach we present here, which chronicles the
academic response to an outbreak, will be useful to assess the
changes in information dissemination that are underway.
Figure 6. Journal Impact factors according to the time of
publication of the 311 selected articles. The journal impact factors
were obtained for 130 journals in which 299 SARS articles were
published, the remaining 12 articles being published in seven journals
that were not indexed in the Journal Citation Report database.
aUp to
and including 5 July 2003, the date WHO declared that the last human
chain of transmission had been broken.
bBetween 6 July to 31
December 2003. Box-plot representation as described in Figure 2
legend: The horizontal line inside the box represents the median; the
lower and upper borders of the box represent the 25th and 75th
percentiles, respectively; the whiskers correspond to extending to 1.5
times the box width (i.e., the IQR) from both ends of the box, and the
circles represent values outside that interval. Whenever the minimum or
maximum observed value is within the whisker interval, the alternative
limit of the corresponding whisker becomes the corresponding
minimum or maximum observed value.
doi:10.1371/journal.pmed.1000272.g006
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Background. Every now and then, a new infectious disease
appears in a human population or an old disease becomes
much more common or more geographically widespread.
Recently, several such ‘‘emerging infectious diseases’’ have
become major public health problems. For example, HIV/
AIDS, hepatitis C, and severe acute respiratory syndrome
(SARS) have all emerged in the past three decades and
spread rapidly round the world. When an outbreak
(epidemic) of an emerging infectious disease occurs,
epidemiologists (scientists who study the causes,
distribution, and control of diseases in populations) swing
into action, collecting and analyzing data on the new threat
to human health. Epidemiological studies are rapidly
launched to identify the causative agent of the new
disease, to investigate how the disease spreads, to define
diagnostic criteria for the disease, to evaluate potential
treatments, and to devise ways to control the disease’s
spread. Public health officials then use the results of these
studies to bring the epidemic under control.
WhyWasThisStudyDone?Clearly,epidemicsofemerging
infectious diseases can only be controlled rapidly and
effectively if the results of epidemiological studies are made
widelyavailableinatimely manner. Public healthbulletins(for
example, the Morbidity and Mortality Weekly Report from the
US Centers from Disease Control and Prevention) are an
important way of disseminating information as is the
publication of original research in peer-reviewed academic
journals. But how timely is this second dissemination route?
Submission, peer-review, revision, re-review, acceptance, and
publication of a piece of academic research can be a long
process, the speed of which is affected by the responses of
both authors and journals. In this study, the researchers
analyze how the results of academic epidemiological research
are submitted and published in journals during and after an
emerging infectious disease epidemic using the 2003 SARS
epidemic as an example. The first case of SARS was identified
in Asia in February 2003 and rapidly spread around the world.
8,098 people became ill with SARS and 774 died before the
epidemic was halted in July 2003.
What Did the Researchers Do and Find? The researchers
identified more than 300 journal articles covering
epidemiological research into the SARS outbreak in Hong
Kong, China, and Toronto, Canada (two cities strongly
affected by the epidemic) that were published online or in
print between January 1, 2003 and July 31, 2007. The
researchers’ analysis of these articles shows that more than
half them were descriptive epidemiological studies,
investigations that focused on describing the distribution
of SARS; a third were analytical epidemiological studies that
tried to discover the cause of SARS. Overall, 22% of the
journal articles were submitted for publication during the
epidemic. Only 8% of the articles were accepted for
publication and only 7% were actually published during
the epidemic. The median (average) submission-to-
acceptance and acceptance-to-publication intervals for
SARS articles submitted during the epidemic were 55 and
77.5 days, respectively, much shorter intervals than those for
non-SARS articles published in the same journal issues. After
the epidemic was over, the submission-to-acceptance and
acceptance-to-publication intervals for SARS articles was
similar to that of non-SARS articles.
What Do These Findings Mean? These findings show
that, although the academic response to the SARS epidemic
was rapid, most articles on the epidemiology of SARS were
published after the epidemic was over even though SARS
was a major threat to public health. Possible reasons for this
publication delay include the time taken by authors to
prepare and undertake their studies, to write and submit
their papers, and, possibly, their tendency to first submit
their results to high profile journals. The time then taken by
journals to review the studies, make decisions about
publication, and complete the publication process might
also have delayed matters. To minimize future delays in the
publication of epidemiological research on emerging
infectious diseases, epidemiologists could adopt common,
predefined protocols and ready-to-use instruments, which
would improve timeliness and ensure comparability across
studies, suggest the researchers. Journals, in turn, could
improve their fast-track procedures and could consider
setting up online sections that could be activated when an
emerging infectious disease outbreak occurred. Finally,
journals could consider altering their review system to
speed up the publication process provided the quality of the
final published articles was not compromised.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000272.
N The US National Institute of Allergy and Infectious Diseases
provides information on emerging infectious diseases
N The US Centers for Control and Prevention of Diseases also
provides information about emerging infectious diseases,
including links to other resources, and information on
SARS
N Wikipedia has a page on epidemiology (note that
Wikipedia is a free online encyclopedia that anyone can
edit; available in several languages)
N The World Health Organization has information on SARS
(in several languages)
Bibliographic Anatomy of SARS Epidemic
PLoS Medicine | www.plosmedicine.org 11 May 2010 | Volume 7 | Issue 5 | e1000272